Evidence map›Paper›PMID 40486010›Full record

ArticleMedical journal of the Islamic Republic of Iran2025

Evaluation of Psoas Muscle Index for Prognosis Prediction in Patients with Ovarian Cancer: A Retrospective 2-Center Cohort Study.

Mahdiss Mohamadianamiri, Mohammadreza Babaei, Arash Mohazzab, Fahimeh Zeinalkhani, Peyman Kamali Hakim, Somayeh Ebadi Soflo, Fatemeh Jayervand, Maryam Noroozi

Abstract read
In one paragraph

Article in Medical journal of the Islamic Republic of Iran, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Mahdiss MohamadianamiriShahid Akbarabadi Clinical Research Development Unit (ShACRDU), Shahid Akbarabadi Obstetrics and Gynecology Hospital, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
Mohammadreza BabaeiDepartment of Interventional Radiology, Firouzgar Hospital, Iran University of Medical Sciences, Tehran, Iran.
Arash MohazzabDepartment of Epidemiology, School of Public Health, Iran University of Medical Sciences, Tehran, Iran.
Fahimeh ZeinalkhaniDepartment of Radiology, Imam Khomeini Hospital, Tehran University of Medical Sciences, Tehran, Iran.
Peyman Kamali HakimDepartment of Radiology, School of Medicine, Iran University of Medical Sciences. Tehran, Iran.
Somayeh Ebadi SofloShahid Akbarabadi Clinical Research Development Unit (ShACRDU), Shahid Akbarabadi Obstetrics and Gynecology Hospital, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
Fatemeh JayervandShahid Akbarabadi Clinical Research Development Unit (ShACRDU), Shahid Akbarabadi Obstetrics and Gynecology Hospital, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
Maryam NorooziShahid Akbarabadi Clinical Research Development Unit (ShACRDU), Shahid Akbarabadi Obstetrics and Gynecology Hospital, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.ORCID https://orcid.org/0009-0003-2007-4314

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Ovarian cancer is a leading cause of death among gynecological cancers. The prognosis depends mainly on the diagnosis stage. Sarcopenia, characterized by muscle wasting, significantly impacts cancer prognosis. This study aimed to examine the importance of the psoas muscle index in predicting outcomes for ovarian cancer patients. Methods: We conducted a retrospective cohort study with 73 patients treated between 2011 and 2021 at Akbarabadi Obstetrics and Gynecology Hospital and Rasool-Akram General Hospital in Tehran, Iran. The psoas muscle index was calculated from the sectional area of the psoas muscle at the third lumbar vertebra using computed tomography (CT) and magnetic resonance imaging (MRI) scans. Data collection included demographic information, cancer stage, pathology, and treatment outcomes. Statistical analyses, including logistic and Cox regressions, evaluated the association between the psoas muscle index and patient outcomes. Results: The psoas muscle index was significantly higher in patients without treatment failure (173 ± 28.94) compared with those with treatment failure (149.75 ± 20.39) ( Conclusion: The findings highlight the importance of sarcopenia in the prognosis of ovarian cancer. This study supports the potential of the psoas muscle index as a noninvasive and accessible prognostic tool in clinical practice.

Indexed as

Cancer SurvivalOvarian CancerPrognosisPsoas Muscle Index

Identifiers

PMID40486010
PMCPMC12138782

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.